I've been thinking about the challenges and opportunities in Brazil's pharma market, as discussed by leaders from Servier and LEO Pharma. What should be the main focus to enhance market access and serve Brazil's population effectively? Share your insights by voting below!

What should be the main focus to improve market access in Brazil's pharma sector?